Medical Care

Global AAV Vector Gene Therapy Market Research Report 2025

The global market for AAV Vector Gene Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
AAV (Adeno-Associated Virus) vector gene therapy is a gene therapy method that uses adeno-associated virus as a vector to deliver, express or repair specific genes in patients. AAV is a non-pathogenic, non-oncogenic virus that is widely used in gene therapy research and clinical trials.
North American market for AAV Vector Gene Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for AAV Vector Gene Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of AAV Vector Gene Therapy include uniQure, Roche, Novartis, BioMarin Pharmaceutical, Ferring Pharmaceuticals A/S, CSL Behring LLC, PTC Therapeutics, Inc., Pfizer Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for AAV Vector Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AAV Vector Gene Therapy.
The AAV Vector Gene Therapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AAV Vector Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AAV Vector Gene Therapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
uniQure
Roche
Novartis
BioMarin Pharmaceutical
Ferring Pharmaceuticals A/S
CSL Behring LLC
PTC Therapeutics, Inc.
Pfizer Inc.
Segment by Type
AAV1
AAV2
AAV8
Other
Segment by Application
Duchenne Dystrophy
Hemophilia
Retinal Diseases
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of AAV Vector Gene Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of AAV Vector Gene Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
1 AAV Vector Gene Therapy Market Overview
1.1 Product Definition
1.2 AAV Vector Gene Therapy by Type
1.2.1 Global AAV Vector Gene Therapy Market Value Comparison by Type (2024 VS 2031)
1.2.2 AAV1
1.2.3 AAV2
1.2.4 AAV8
1.2.5 Other
1.3 AAV Vector Gene Therapy by Application
1.3.1 Global AAV Vector Gene Therapy Market Value by Application (2024 VS 2031)
1.3.2 Duchenne Dystrophy
1.3.3 Hemophilia
1.3.4 Retinal Diseases
1.3.5 Other
1.4 Global AAV Vector Gene Therapy Market Size Estimates and Forecasts
1.4.1 Global AAV Vector Gene Therapy Revenue 2020-2031
1.4.2 Global AAV Vector Gene Therapy Sales 2020-2031
1.4.3 Global AAV Vector Gene Therapy Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 AAV Vector Gene Therapy Market Competition by Manufacturers
2.1 Global AAV Vector Gene Therapy Sales Market Share by Manufacturers (2020-2025)
2.2 Global AAV Vector Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
2.3 Global AAV Vector Gene Therapy Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of AAV Vector Gene Therapy, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of AAV Vector Gene Therapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of AAV Vector Gene Therapy, Product Type & Application
2.7 Global Key Manufacturers of AAV Vector Gene Therapy, Date of Enter into This Industry
2.8 Global AAV Vector Gene Therapy Market Competitive Situation and Trends
2.8.1 Global AAV Vector Gene Therapy Market Concentration Rate
2.8.2 The Global 5 and 10 Largest AAV Vector Gene Therapy Players Market Share by Revenue
2.8.3 Global AAV Vector Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global AAV Vector Gene Therapy Market Scenario by Region
3.1 Global AAV Vector Gene Therapy Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global AAV Vector Gene Therapy Sales by Region: 2020-2031
3.2.1 Global AAV Vector Gene Therapy Sales by Region: 2020-2025
3.2.2 Global AAV Vector Gene Therapy Sales by Region: 2026-2031
3.3 Global AAV Vector Gene Therapy Revenue by Region: 2020-2031
3.3.1 Global AAV Vector Gene Therapy Revenue by Region: 2020-2025
3.3.2 Global AAV Vector Gene Therapy Revenue by Region: 2026-2031
3.4 North America AAV Vector Gene Therapy Market Facts & Figures by Country
3.4.1 North America AAV Vector Gene Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America AAV Vector Gene Therapy Sales by Country (2020-2031)
3.4.3 North America AAV Vector Gene Therapy Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe AAV Vector Gene Therapy Market Facts & Figures by Country
3.5.1 Europe AAV Vector Gene Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe AAV Vector Gene Therapy Sales by Country (2020-2031)
3.5.3 Europe AAV Vector Gene Therapy Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific AAV Vector Gene Therapy Market Facts & Figures by Region
3.6.1 Asia Pacific AAV Vector Gene Therapy Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific AAV Vector Gene Therapy Sales by Region (2020-2031)
3.6.3 Asia Pacific AAV Vector Gene Therapy Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America AAV Vector Gene Therapy Market Facts & Figures by Country
3.7.1 Latin America AAV Vector Gene Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America AAV Vector Gene Therapy Sales by Country (2020-2031)
3.7.3 Latin America AAV Vector Gene Therapy Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa AAV Vector Gene Therapy Market Facts & Figures by Country
3.8.1 Middle East and Africa AAV Vector Gene Therapy Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa AAV Vector Gene Therapy Sales by Country (2020-2031)
3.8.3 Middle East and Africa AAV Vector Gene Therapy Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global AAV Vector Gene Therapy Sales by Type (2020-2031)
4.1.1 Global AAV Vector Gene Therapy Sales by Type (2020-2025)
4.1.2 Global AAV Vector Gene Therapy Sales by Type (2026-2031)
4.1.3 Global AAV Vector Gene Therapy Sales Market Share by Type (2020-2031)
4.2 Global AAV Vector Gene Therapy Revenue by Type (2020-2031)
4.2.1 Global AAV Vector Gene Therapy Revenue by Type (2020-2025)
4.2.2 Global AAV Vector Gene Therapy Revenue by Type (2026-2031)
4.2.3 Global AAV Vector Gene Therapy Revenue Market Share by Type (2020-2031)
4.3 Global AAV Vector Gene Therapy Price by Type (2020-2031)
5 Segment by Application
5.1 Global AAV Vector Gene Therapy Sales by Application (2020-2031)
5.1.1 Global AAV Vector Gene Therapy Sales by Application (2020-2025)
5.1.2 Global AAV Vector Gene Therapy Sales by Application (2026-2031)
5.1.3 Global AAV Vector Gene Therapy Sales Market Share by Application (2020-2031)
5.2 Global AAV Vector Gene Therapy Revenue by Application (2020-2031)
5.2.1 Global AAV Vector Gene Therapy Revenue by Application (2020-2025)
5.2.2 Global AAV Vector Gene Therapy Revenue by Application (2026-2031)
5.2.3 Global AAV Vector Gene Therapy Revenue Market Share by Application (2020-2031)
5.3 Global AAV Vector Gene Therapy Price by Application (2020-2031)
6 Key Companies Profiled
6.1 uniQure
6.1.1 uniQure Company Information
6.1.2 uniQure Description and Business Overview
6.1.3 uniQure AAV Vector Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.1.4 uniQure AAV Vector Gene Therapy Product Portfolio
6.1.5 uniQure Recent Developments/Updates
6.2 Roche
6.2.1 Roche Company Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche AAV Vector Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Roche AAV Vector Gene Therapy Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Company Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis AAV Vector Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis AAV Vector Gene Therapy Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 BioMarin Pharmaceutical
6.4.1 BioMarin Pharmaceutical Company Information
6.4.2 BioMarin Pharmaceutical Description and Business Overview
6.4.3 BioMarin Pharmaceutical AAV Vector Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.4.4 BioMarin Pharmaceutical AAV Vector Gene Therapy Product Portfolio
6.4.5 BioMarin Pharmaceutical Recent Developments/Updates
6.5 Ferring Pharmaceuticals A/S
6.5.1 Ferring Pharmaceuticals A/S Company Information
6.5.2 Ferring Pharmaceuticals A/S Description and Business Overview
6.5.3 Ferring Pharmaceuticals A/S AAV Vector Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Ferring Pharmaceuticals A/S AAV Vector Gene Therapy Product Portfolio
6.5.5 Ferring Pharmaceuticals A/S Recent Developments/Updates
6.6 CSL Behring LLC
6.6.1 CSL Behring LLC Company Information
6.6.2 CSL Behring LLC Description and Business Overview
6.6.3 CSL Behring LLC AAV Vector Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.6.4 CSL Behring LLC AAV Vector Gene Therapy Product Portfolio
6.6.5 CSL Behring LLC Recent Developments/Updates
6.7 PTC Therapeutics, Inc.
6.7.1 PTC Therapeutics, Inc. Company Information
6.7.2 PTC Therapeutics, Inc. Description and Business Overview
6.7.3 PTC Therapeutics, Inc. AAV Vector Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.7.4 PTC Therapeutics, Inc. AAV Vector Gene Therapy Product Portfolio
6.7.5 PTC Therapeutics, Inc. Recent Developments/Updates
6.8 Pfizer Inc.
6.8.1 Pfizer Inc. Company Information
6.8.2 Pfizer Inc. Description and Business Overview
6.8.3 Pfizer Inc. AAV Vector Gene Therapy Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Pfizer Inc. AAV Vector Gene Therapy Product Portfolio
6.8.5 Pfizer Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 AAV Vector Gene Therapy Industry Chain Analysis
7.2 AAV Vector Gene Therapy Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 AAV Vector Gene Therapy Production Mode & Process Analysis
7.4 AAV Vector Gene Therapy Sales and Marketing
7.4.1 AAV Vector Gene Therapy Sales Channels
7.4.2 AAV Vector Gene Therapy Distributors
7.5 AAV Vector Gene Therapy Customer Analysis
8 AAV Vector Gene Therapy Market Dynamics
8.1 AAV Vector Gene Therapy Industry Trends
8.2 AAV Vector Gene Therapy Market Drivers
8.3 AAV Vector Gene Therapy Market Challenges
8.4 AAV Vector Gene Therapy Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global AAV Vector Gene Therapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global AAV Vector Gene Therapy Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global AAV Vector Gene Therapy Market Competitive Situation by Manufacturers in 2024
Table 4. Global AAV Vector Gene Therapy Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global AAV Vector Gene Therapy Sales Market Share by Manufacturers (2020-2025)
Table 6. Global AAV Vector Gene Therapy Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global AAV Vector Gene Therapy Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market AAV Vector Gene Therapy Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of AAV Vector Gene Therapy, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of AAV Vector Gene Therapy, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of AAV Vector Gene Therapy, Product Type & Application
Table 12. Global Key Manufacturers of AAV Vector Gene Therapy, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global AAV Vector Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AAV Vector Gene Therapy as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global AAV Vector Gene Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global AAV Vector Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 18. Global AAV Vector Gene Therapy Sales Market Share by Region (2020-2025)
Table 19. Global AAV Vector Gene Therapy Sales by Region (2026-2031) & (K Units)
Table 20. Global AAV Vector Gene Therapy Sales Market Share by Region (2026-2031)
Table 21. Global AAV Vector Gene Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global AAV Vector Gene Therapy Revenue Market Share by Region (2020-2025)
Table 23. Global AAV Vector Gene Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global AAV Vector Gene Therapy Revenue Market Share by Region (2026-2031)
Table 25. North America AAV Vector Gene Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America AAV Vector Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 27. North America AAV Vector Gene Therapy Sales by Country (2026-2031) & (K Units)
Table 28. North America AAV Vector Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America AAV Vector Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe AAV Vector Gene Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe AAV Vector Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 32. Europe AAV Vector Gene Therapy Sales by Country (2026-2031) & (K Units)
Table 33. Europe AAV Vector Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe AAV Vector Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific AAV Vector Gene Therapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific AAV Vector Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific AAV Vector Gene Therapy Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific AAV Vector Gene Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific AAV Vector Gene Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America AAV Vector Gene Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America AAV Vector Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 42. Latin America AAV Vector Gene Therapy Sales by Country (2026-2031) & (K Units)
Table 43. Latin America AAV Vector Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America AAV Vector Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa AAV Vector Gene Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa AAV Vector Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa AAV Vector Gene Therapy Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa AAV Vector Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa AAV Vector Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global AAV Vector Gene Therapy Sales (K Units) by Type (2020-2025)
Table 51. Global AAV Vector Gene Therapy Sales (K Units) by Type (2026-2031)
Table 52. Global AAV Vector Gene Therapy Sales Market Share by Type (2020-2025)
Table 53. Global AAV Vector Gene Therapy Sales Market Share by Type (2026-2031)
Table 54. Global AAV Vector Gene Therapy Revenue (US$ Million) by Type (2020-2025)
Table 55. Global AAV Vector Gene Therapy Revenue (US$ Million) by Type (2026-2031)
Table 56. Global AAV Vector Gene Therapy Revenue Market Share by Type (2020-2025)
Table 57. Global AAV Vector Gene Therapy Revenue Market Share by Type (2026-2031)
Table 58. Global AAV Vector Gene Therapy Price (US$/Unit) by Type (2020-2025)
Table 59. Global AAV Vector Gene Therapy Price (US$/Unit) by Type (2026-2031)
Table 60. Global AAV Vector Gene Therapy Sales (K Units) by Application (2020-2025)
Table 61. Global AAV Vector Gene Therapy Sales (K Units) by Application (2026-2031)
Table 62. Global AAV Vector Gene Therapy Sales Market Share by Application (2020-2025)
Table 63. Global AAV Vector Gene Therapy Sales Market Share by Application (2026-2031)
Table 64. Global AAV Vector Gene Therapy Revenue (US$ Million) by Application (2020-2025)
Table 65. Global AAV Vector Gene Therapy Revenue (US$ Million) by Application (2026-2031)
Table 66. Global AAV Vector Gene Therapy Revenue Market Share by Application (2020-2025)
Table 67. Global AAV Vector Gene Therapy Revenue Market Share by Application (2026-2031)
Table 68. Global AAV Vector Gene Therapy Price (US$/Unit) by Application (2020-2025)
Table 69. Global AAV Vector Gene Therapy Price (US$/Unit) by Application (2026-2031)
Table 70. uniQure Company Information
Table 71. uniQure Description and Business Overview
Table 72. uniQure AAV Vector Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. uniQure AAV Vector Gene Therapy Product
Table 74. uniQure Recent Developments/Updates
Table 75. Roche Company Information
Table 76. Roche Description and Business Overview
Table 77. Roche AAV Vector Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Roche AAV Vector Gene Therapy Product
Table 79. Roche Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis AAV Vector Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Novartis AAV Vector Gene Therapy Product
Table 84. Novartis Recent Developments/Updates
Table 85. BioMarin Pharmaceutical Company Information
Table 86. BioMarin Pharmaceutical Description and Business Overview
Table 87. BioMarin Pharmaceutical AAV Vector Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. BioMarin Pharmaceutical AAV Vector Gene Therapy Product
Table 89. BioMarin Pharmaceutical Recent Developments/Updates
Table 90. Ferring Pharmaceuticals A/S Company Information
Table 91. Ferring Pharmaceuticals A/S Description and Business Overview
Table 92. Ferring Pharmaceuticals A/S AAV Vector Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Ferring Pharmaceuticals A/S AAV Vector Gene Therapy Product
Table 94. Ferring Pharmaceuticals A/S Recent Developments/Updates
Table 95. CSL Behring LLC Company Information
Table 96. CSL Behring LLC Description and Business Overview
Table 97. CSL Behring LLC AAV Vector Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. CSL Behring LLC AAV Vector Gene Therapy Product
Table 99. CSL Behring LLC Recent Developments/Updates
Table 100. PTC Therapeutics, Inc. Company Information
Table 101. PTC Therapeutics, Inc. Description and Business Overview
Table 102. PTC Therapeutics, Inc. AAV Vector Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. PTC Therapeutics, Inc. AAV Vector Gene Therapy Product
Table 104. PTC Therapeutics, Inc. Recent Developments/Updates
Table 105. Pfizer Inc. Company Information
Table 106. Pfizer Inc. Description and Business Overview
Table 107. Pfizer Inc. AAV Vector Gene Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Pfizer Inc. AAV Vector Gene Therapy Product
Table 109. Pfizer Inc. Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. AAV Vector Gene Therapy Distributors List
Table 113. AAV Vector Gene Therapy Customers List
Table 114. AAV Vector Gene Therapy Market Trends
Table 115. AAV Vector Gene Therapy Market Drivers
Table 116. AAV Vector Gene Therapy Market Challenges
Table 117. AAV Vector Gene Therapy Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report


List of Figures
Figure 1. Product Picture of AAV Vector Gene Therapy
Figure 2. Global AAV Vector Gene Therapy Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global AAV Vector Gene Therapy Market Share by Type: 2024 & 2031
Figure 4. AAV1 Product Picture
Figure 5. AAV2 Product Picture
Figure 6. AAV8 Product Picture
Figure 7. Other Product Picture
Figure 8. Global AAV Vector Gene Therapy Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global AAV Vector Gene Therapy Market Share by Application: 2024 & 2031
Figure 10. Duchenne Dystrophy
Figure 11. Hemophilia
Figure 12. Retinal Diseases
Figure 13. Other
Figure 14. Global AAV Vector Gene Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global AAV Vector Gene Therapy Market Size (2020-2031) & (US$ Million)
Figure 16. Global AAV Vector Gene Therapy Sales (2020-2031) & (K Units)
Figure 17. Global AAV Vector Gene Therapy Average Price (US$/Unit) & (2020-2031)
Figure 18. AAV Vector Gene Therapy Report Years Considered
Figure 19. AAV Vector Gene Therapy Sales Share by Manufacturers in 2024
Figure 20. Global AAV Vector Gene Therapy Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest AAV Vector Gene Therapy Players: Market Share by Revenue in AAV Vector Gene Therapy in 2024
Figure 22. AAV Vector Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global AAV Vector Gene Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America AAV Vector Gene Therapy Sales Market Share by Country (2020-2031)
Figure 25. North America AAV Vector Gene Therapy Revenue Market Share by Country (2020-2031)
Figure 26. United States AAV Vector Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada AAV Vector Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe AAV Vector Gene Therapy Sales Market Share by Country (2020-2031)
Figure 29. Europe AAV Vector Gene Therapy Revenue Market Share by Country (2020-2031)
Figure 30. Germany AAV Vector Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France AAV Vector Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. AAV Vector Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy AAV Vector Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia AAV Vector Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific AAV Vector Gene Therapy Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific AAV Vector Gene Therapy Revenue Market Share by Region (2020-2031)
Figure 37. China AAV Vector Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan AAV Vector Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea AAV Vector Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India AAV Vector Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia AAV Vector Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan AAV Vector Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Southeast Asia AAV Vector Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America AAV Vector Gene Therapy Sales Market Share by Country (2020-2031)
Figure 45. Latin America AAV Vector Gene Therapy Revenue Market Share by Country (2020-2031)
Figure 46. Mexico AAV Vector Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil AAV Vector Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina AAV Vector Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa AAV Vector Gene Therapy Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa AAV Vector Gene Therapy Revenue Market Share by Country (2020-2031)
Figure 51. Turkey AAV Vector Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia AAV Vector Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE AAV Vector Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of AAV Vector Gene Therapy by Type (2020-2031)
Figure 55. Global Revenue Market Share of AAV Vector Gene Therapy by Type (2020-2031)
Figure 56. Global AAV Vector Gene Therapy Price (US$/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of AAV Vector Gene Therapy by Application (2020-2031)
Figure 58. Global Revenue Market Share of AAV Vector Gene Therapy by Application (2020-2031)
Figure 59. Global AAV Vector Gene Therapy Price (US$/Unit) by Application (2020-2031)
Figure 60. AAV Vector Gene Therapy Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies